Search research articles
Contact Us
Filters
Showing results (71-80 of 149) with videos related to
Page
of 15
Sort By:
Annals of the American Thoracic Society
|
November 5, 2019
The Minimum Clinically Important Difference of the Incremental Shuttle Walk Test in Bronchiectasis: A Prospective Cohort Study
Jessica A Walsh, Suhani Patel, Ruth E Barker, et al.
American Journal of Respiratory and Critical Care Medicine
|
March 20, 2015
Chronic Infection by Mucoid Pseudomonas aeruginosa Associated with Dysregulation in T-Cell Immunity to Outer Membrane Porin F
Kathryn J Quigley, Catherine J Reynolds, Amelie Goudet, et al.
Breathe (Sheffield, England)
|
September 13, 2017
The European Multicentre Bronchiectasis Audit and Research Collaboration (EMBARC): experiences from a successful ERS Clinical Research Collaboration
James D Chalmers, Megan Crichton, Pieter C Goeminne, et al.
The New England Journal of Medicine
|
September 8, 2020
Phase 2 Trial of the DPP-1 Inhibitor Brensocatib in Bronchiectasis
James D Chalmers, Charles S Haworth, Mark L Metersky, et al.
Breathe (Sheffield, England)
|
December 7, 2018
ERS syllabus for postgraduate training in respiratory infections: a guide for comprehensive training
Stefano Aliberti, Amy Farr, Nathalie Tabin, et al.
The European Respiratory Journal
|
April 23, 2021
Psychometrics of health-related quality of life questionnaires in bronchiectasis: a systematic review and meta-analysis
Rebecca H McLeese, Arietta Spinou, Zina Alfahl, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society
|
July 25, 2022
An invisible threat? Aspergillus positive cultures and co-infecting bacteria in airway samples
Dominic A Hughes, Mark Rosenthal, Leah Cuthbertson, et al.
The European Respiratory Journal
|
August 29, 2020
Efficacy and safety of TOBI Podhaler in <i>Pseudomonas aeruginosa-</i>infected bronchiectasis patients: iBEST study
Michael R Loebinger, Eva Polverino, James D Chalmers, et al.
ERJ Open Research
|
December 10, 2024
Automated method of bronchus and artery dimension measurement in an adult bronchiectasis population
Angelina L P Pieters, Qianting Lv, Jennifer J Meerburg, et al.
The Lancet. Respiratory Medicine
|
September 3, 2023
Safety and efficacy of the epithelial sodium channel blocker idrevloride in people with primary ciliary dyskinesia (CLEAN-PCD): a multinational, phase 2, randomised, double-blind, placebo-controlled crossover trial
Felix C Ringshausen, Adam J Shapiro, Kim G Nielsen, et al.
Page
of 15
Search research articles
Search
Showing results (71-80 of 149) with videos related to
Sort By:
Page
of 15
Annals of the American Thoracic Society
|
November 5, 2019
The Minimum Clinically Important Difference of the Incremental Shuttle Walk Test in Bronchiectasis: A Prospective Cohort Study
Jessica A Walsh, Suhani Patel, Ruth E Barker, et al.
American Journal of Respiratory and Critical Care Medicine
|
March 20, 2015
Chronic Infection by Mucoid Pseudomonas aeruginosa Associated with Dysregulation in T-Cell Immunity to Outer Membrane Porin F
Kathryn J Quigley, Catherine J Reynolds, Amelie Goudet, et al.
Breathe (Sheffield, England)
|
September 13, 2017
The European Multicentre Bronchiectasis Audit and Research Collaboration (EMBARC): experiences from a successful ERS Clinical Research Collaboration
James D Chalmers, Megan Crichton, Pieter C Goeminne, et al.
The New England Journal of Medicine
|
September 8, 2020
Phase 2 Trial of the DPP-1 Inhibitor Brensocatib in Bronchiectasis
James D Chalmers, Charles S Haworth, Mark L Metersky, et al.
Breathe (Sheffield, England)
|
December 7, 2018
ERS syllabus for postgraduate training in respiratory infections: a guide for comprehensive training
Stefano Aliberti, Amy Farr, Nathalie Tabin, et al.
The European Respiratory Journal
|
April 23, 2021
Psychometrics of health-related quality of life questionnaires in bronchiectasis: a systematic review and meta-analysis
Rebecca H McLeese, Arietta Spinou, Zina Alfahl, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society
|
July 25, 2022
An invisible threat? Aspergillus positive cultures and co-infecting bacteria in airway samples
Dominic A Hughes, Mark Rosenthal, Leah Cuthbertson, et al.
The European Respiratory Journal
|
August 29, 2020
Efficacy and safety of TOBI Podhaler in <i>Pseudomonas aeruginosa-</i>infected bronchiectasis patients: iBEST study
Michael R Loebinger, Eva Polverino, James D Chalmers, et al.
ERJ Open Research
|
December 10, 2024
Automated method of bronchus and artery dimension measurement in an adult bronchiectasis population
Angelina L P Pieters, Qianting Lv, Jennifer J Meerburg, et al.
The Lancet. Respiratory Medicine
|
September 3, 2023
Safety and efficacy of the epithelial sodium channel blocker idrevloride in people with primary ciliary dyskinesia (CLEAN-PCD): a multinational, phase 2, randomised, double-blind, placebo-controlled crossover trial
Felix C Ringshausen, Adam J Shapiro, Kim G Nielsen, et al.
Page
of 15